Skip to content Skip to footer

Research Portal of the TU Dresden

Interferon signature guiding therapeutic decision making: Ruxolitinib as first-line therapy for severe juvenile dermatomyositis?

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

André Heinen - , Department of Paediatrics (Author)
Anja Schnabel - , Department of Paediatrics (Author)
Normi Brück - , Department of Paediatrics (Author)
Martin Smitka - , Department of Paediatrics, Division of Neuropediatrics (Author)
Christine Wolf - , Department of Paediatrics (Author)
Nadja Lucas - , Department of Paediatrics (Author)
Stefanie Dollinger - , German Center for Pediatric and Adolescent Rheumatology (Author)
Gabriele Hahn - , Institute and Polyclinic of Diagnostic and Interventional Radiology (Author)
Claudia Günther - , Department of Dermatology (Author)
Reinhard Berner - , Department of Paediatrics (Author)
Min Ae Lee-Kirsch - , Department of Paediatrics (Author)
Catharina Schuetz - , Department of Paediatrics (Author)

Details

Original language	English
Pages (from-to)	E136-E138
Number of pages	3
Journal	Rheumatology
Volume	60
Issue number	4
Publication status	Published - Apr 2021
Peer-reviewed	Yes

External IDs

PubMed	33200187
ORCID	/0000-0002-4330-1861/work/145223757
ORCID	/0009-0003-6519-0482/work/145224171

Keywords

ASJC Scopus subject areas

Rheumatology

Library keywords

610 Medicine and health